The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
April 16th 2025
An emerging nomogram model for intra-tumoral heterogeneity quantification with breast MRI demonstrated an average 85 percent sensitivity in external validation testing for predicting pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
MRI predicts prostate cancer prognosis
May 14th 2008Researchers in San Francisco have found that MR imaging can accurately predict recurrence and development of metastatic disease in patients who are about to undergo radiation therapy for prostate cancer. Study findings suggest a stronger role for MRI in the management of the condition.
Hitachi primes 1.2T Oasis for commercial launch
May 9th 2008Hitachi executives hope their booth at the ISMRM meeting will serve as a springboard for sales of their open 1.2T Oasis, set to begin shipping this month. The new high-field scanner is the company’s chance to rekindle a market that has all but collapsed in the past several years with the advent of compact wide-bore 1.5T devices and expanding clinical applications for such high-performance systems.
Siemens casts Tim as its unifying thread
May 9th 2008Above and around the Siemens Healthcare booth at the ISMRM meeting, the message “pushing the boundaries of MR” was as clear as it could be. The theme was driven home by pennants featuring iconic reconstructions of athletes into whole-body 2D renditions of muscles and organs. How the company pushes these boundaries, however, had been more subtext than headline, an issue Siemens vice president of marketing for MR Don Fowler set out to resolve on the ISMRM exhibit floor.
Functional brain mapping boosts early assessment of brain cancer treatment response
May 9th 2008The first three months after standard radiation therapy for a brain tumor must be hell for patients and their families. The established MacDonald criteria for assessing treatment force them to wait up to 10 weeks for follow-up CT or MR to determine if the size of the treated tumor has changed.
Cardiac coil boosts data acquisition on Toshiba 1.5T
May 7th 2008Quality Electrodynamics has constructed and tested a 32-channel cardiac array for use on the Toshiba 1.5T Vantage Atlas that its developers say will provide acceleration factors in any direction, including oblique phase-encoding, which is often applied in cardiac imaging.
Kaiser study of 3.3 million members finds single case of NSF
May 7th 2008A comprehensive evaluation of Magnevist use among the 3.3 million members of Kaiser Permanente in Northern California has found a lower risk for developing nephrogenic systemic fibrosis than reported in previous studies in renal disease patients who received gadolinium-based MR contrast media.
Philips advances quantitative MR
May 7th 2008Quantitative MR, characterized by the precise measurement of data points that underlie MR images, may one day provide an exact and definable basis to recognize the early signs of disease and response to therapy. Philips Healthcare is moving toward that day, developing techniques that quantify the presence of cancerous tumors and heart disease.
Desk-sized MR scanner shows potential for rheumatoid arthritis patients
May 7th 2008Assessment with MR is essential for the early detection of rheumatoid arthritis in the hands and the monitoring of drug therapy, but hand studies are not cost effective. That’s where the Japanese firm MR Technology of Tsukuba, in the prefecture of Ibaraki, comes in.
Merck plans evaluation of spin-signal MR
May 6th 2008GE Healthcare’s gas-based MRI imaging strategy may find a home, if tests of the technology by Merck pan out. The pharmaceutical company plans to audition GE’s Spin Signal Technology (SST) utilizing hyperpolarized xenon 129 gas for use in assessing its experimental respiratory treatments.
GE launches fast, easy-to-use 3T scanner
May 5th 2008GE has unveiled a new 3T scanner, the Signa MR750, the first in a new generation of Signa scanners designed to handle the toughest imaging cases with minimal effort. More powerful gradients, increased anatomical coverage, enhanced parallel imaging, and a user interface that simplifies routine as well as academically challenging protocols promise to allow 3T to reach its clinical potential, said Jim Davis, GE vice president and general manager of global MR business.
ISMRM presentations reflect MR’s varied role in practice and research
May 4th 2008Visitors to the 2008 International Society for Magnetic Resonance in Medicine meeting in Toronto need only wait a minute for the door to swing from clinical issues to advanced research on functional and metabolic imaging.
Added padding: One solution to patient comfort
May 1st 2008A couple of days ago I was in the zone. Shawna’s surgical mask hid her face, but I knew she was smiling. My banter was enough to make her laugh out loud a few times, so much that she paused while laying out the stainless steel instruments that soon would be probing the all too deep pockets between my teeth and gums.
Brain stays cool as jazz man jams
May 1st 2008To the listener, jazz improvisation is an aural flight of fancy, borne aloft by a musician's on-the-spot skill and imagination. But functional MRI results show the brain actually follows a grounded process of activation and deactivation during these spontaneous musical riffs, according to researchers from the National Institutes of Health and Johns Hopkins University.